The Long Run with Luke Timmerman
1,731 FOLLOWERS
Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech's relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great..
The Long Run with Luke Timmerman
3d ago
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine ..read more
The Long Run with Luke Timmerman
3M ago
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery ..read more
The Long Run with Luke Timmerman
3M ago
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging ..read more
The Long Run with Luke Timmerman
4M ago
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer ..read more
The Long Run with Luke Timmerman
4M ago
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery ..read more
The Long Run with Luke Timmerman
5M ago
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery ..read more
The Long Run with Luke Timmerman
5M ago
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases ..read more
The Long Run with Luke Timmerman
6M ago
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine ..read more
The Long Run with Luke Timmerman
6M ago
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech ..read more
The Long Run with Luke Timmerman
7M ago
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer ..read more